Tipranavir bulk supplier for pharma manufacturers

Tipranavir 250 mg, 100 mg/mL Suppliers & Bulk Manufacturers

Available Forms: Capsules / Oral Solution

Available Strengths: 250 mg, 100 mg/mL

Reference Brands: Aptivus (USA/EU)

Tipranavir is an antiretroviral medication belonging to the protease inhibitor class. It is used in combination with ritonavir and other antiretroviral agents to treat HIV-1 infection in patients who have developed resistance to other HIV drugs. Tipranavir works by blocking the HIV protease enzyme, which prevents the virus from multiplying and lowers the amount of HIV in the blood.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Tipranavir — third party manufacturing & bulk supply

Tipranavir 250 mg, 100 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Tipranavir is supplied as Capsules / Oral Solution — supplied in more than one dosage form, each with its own manufacturing economics, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Tipranavir listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Tipranavir →

Back to Listing

Frequently Asked Questions

Tipranavir is used in combination with ritonavir and other antiretroviral medicines for the treatment of HIV-1 infection in patients who have experienced resistance to multiple protease inhibitors. It helps reduce viral load by inhibiting the HIV protease enzyme, preventing the virus from maturing and multiplying.

Tipranavir is a synthetic non-peptidic protease inhibitor. Its chemical structure is designed to bind to the active site of HIV-1 protease, blocking the enzyme’s function and preventing the formation of infectious viral particles.

The most recognized trade name for Tipranavir is Aptivus.

Aptivus is manufactured by Boehringer Ingelheim.

The generic name of the product is tipranavir.

The commonly known brand name is Aptivus.

Tipranavir (Aptivus) is manufactured by Boehringer Ingelheim in its approved global production facilities. Distribution varies by region based on regulatory approvals.